Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Medican A/S

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 N/A 2017 N/A 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 0.0% 5.2% 3.7% 5.4% 6.5% 9.7% 9.7%   Credit score (0-100)   0 0 44 53 42 35 24 24   Credit rating   N/A N/A BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 N/A 2017 N/A 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 0.0 -12,457 -9,763 -10,145 -9,237 0.0 0.0   EBITDA   0.0 0.0 -17,712 -19,790 -22,920 -20,047 0.0 0.0   EBIT   0.0 0.0 -17,712 -22,272 -26,237 -23,510 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 -30,939.1 -22,289.7 -22,178.8 -46,208.5 0.0 0.0   Net earnings   0.0 0.0 -27,057.0 -17,400.4 -15,037.3 -39,688.3 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 -30,939 -22,290 -22,179 -46,209 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 N/A 2017 N/A 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Tangible assets total   0.0 0.0 9,065 13,430 11,514 9,022 0.0 0.0   Shareholders equity total   0.0 0.0 22,880 31,211 31,397 15,546 11,485 11,485   Interest-bearing liabilities   0.0 0.0 0.0 987 30,281 21,136 0.0 0.0   Balance sheet total (assets)   0.0 0.0 25,226 42,850 67,824 39,606 11,485 11,485   Net Debt   0.0 0.0 -4,896 454 29,204 19,241 -11,485 -11,485     See the entire balance sheet 1000.0 Volume  2016 N/A 2017 N/A 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 0.0 -12,457 -9,763 -10,145 -9,237 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 21.6% -3.9% 9.0% 0.0% 0.0%   Employees   0 0 10 17 17 16 0 0   Employee growth %   0.0% 0.0% 0.0% 70.0% 0.0% -5.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 25,226 42,850 67,824 39,606 11,485 11,485   Balance sheet change%   0.0% 0.0% 0.0% 69.9% 58.3% -41.6% -71.0% 0.0%   Added value   0.0 0.0 -17,712.4 -19,790.3 -23,755.5 -20,047.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 9,065 1,884 -4,643 -2,929 -12,639 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 0.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2016 N/A 2017 N/A 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 142.2% 228.1% 258.6% 254.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 0.0% -122.3% -65.1% -37.6% -80.1% 0.0% 0.0%   ROI %   0.0% 0.0% -134.8% -80.5% -44.0% -86.1% 0.0% 0.0%   ROE %   0.0% 0.0% -118.3% -64.3% -48.0% -169.1% 0.0% 0.0%   1000.0 Solidity  2016 N/A 2017 N/A 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Equity ratio %   0.0% 0.0% 90.7% 72.8% 46.3% 39.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 27.6% -2.3% -127.4% -96.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 3.2% 96.4% 136.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 24.5% 8.6% 12.4% 0.0% 0.0%   1000.0 Liquidity  2016 N/A 2017 N/A 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Quick Ratio   0.0 0.0 5.5 1.4 6.7 1.2 0.0 0.0   Current Ratio   0.0 0.0 6.7 1.4 7.1 1.3 0.0 0.0   Cash and cash equivalent   0.0 0.0 4,896.0 533.3 1,077.2 1,895.4 0.0 0.0   1000.0 Capital use efficiency  2016 N/A 2017 N/A 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 13,326.2 4,456.3 36,776.5 6,213.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 N/A 2017 N/A 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 -1,771 -1,164 -1,397 -1,253 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 -1,771 -1,164 -1,348 -1,253 0 0   EBIT / employee   0 0 -1,771 -1,310 -1,543 -1,469 0 0   Net earnings / employee   0 0 -2,706 -1,024 -885 -2,481 0 0